Impact of pregabalin reclassification as a controlled substance in Egypt on gabapentinoid and opioid utilization: A repeated cross-sectional study

Araniy Santhireswaran, Simon LaRue, Shanzeh Chaudhry, Yilei Liu, Katie Suda, Omneya Mohamed, Mohamed Amin, Jason Guertin, Mina Tadrous

Open source

DOI: 10.1371/journal.pone.0337833
Published: 2025-12-05
Container: PLOS One
Publisher: Public Library of Science (PLoS)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1371/journal.pone.0337833,
  title = {Impact of pregabalin reclassification as a controlled substance in Egypt on gabapentinoid and opioid utilization: A repeated cross-sectional study},
  author = {Araniy Santhireswaran and Simon LaRue and Shanzeh Chaudhry and Yilei Liu and Katie Suda and Omneya Mohamed and Mohamed Amin and Jason Guertin and Mina Tadrous},
  year = {2025},
  journal = {PLOS One},
  doi = {10.1371/journal.pone.0337833},
  url = {https://doi.org/10.1371/journal.pone.0337833}
}

RIS

TY  - JOUR
TI  - Impact of pregabalin reclassification as a controlled substance in Egypt on gabapentinoid and opioid utilization: A repeated cross-sectional study
AU  - Araniy Santhireswaran
AU  - Simon LaRue
AU  - Shanzeh Chaudhry
AU  - Yilei Liu
AU  - Katie Suda
AU  - Omneya Mohamed
AU  - Mohamed Amin
AU  - Jason Guertin
AU  - Mina Tadrous
PY  - 2025
JO  - PLOS One
DO  - 10.1371/journal.pone.0337833
UR  - https://doi.org/10.1371/journal.pone.0337833
ER  -

APA

Santhireswaran, A., LaRue, S., Chaudhry, S., Liu, Y., Suda, K., Mohamed, O., Amin, M., Guertin, J., & Tadrous, M. (2025). Impact of pregabalin reclassification as a controlled substance in Egypt on gabapentinoid and opioid utilization: A repeated cross-sectional study. PLOS One. https://doi.org/10.1371/journal.pone.0337833

Source records

crossref · retrieved 2026-09-25T13:21:45.256Z